Bank of Hawaii’s AbbVie ABBV Stock Holding History

Bank of Hawaii’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.69M	Sell	26,176 -2,699	-9%	-$599K	0.3%	46
2025 Q4	$6.6M	Sell	28,875 -494	-2%	-$113K	0.33%	39
2025 Q3	$6.8M	Sell	29,369 -3,585	-11%	-$730K	0.34%	41
2025 Q2	$6.12M	Buy	32,954 +1,523	+5%	+$283K	0.32%	45
2025 Q1	$6.59M	Buy	31,431 +197	+0.6%	+$38.3K	0.38%	39
2024 Q4	$5.55M	Sell	31,234 -597	-2%	-$110K	0.31%	46
2024 Q3	$6.29M	Sell	31,831 -815	-2%	-$152K	0.26%	43
2024 Q2	$5.6M	Sell	32,646 -1,120	-3%	-$186K	0.26%	43
2024 Q1	$6.15M	Sell	33,766 -2,082	-6%	-$359K	0.3%	39
2023 Q4	$5.56M	Sell	35,848 -1,892	-5%	-$276K	0.3%	41
2023 Q3	$5.63M	Sell	37,740 -1,213	-3%	-$178K	0.32%	40
2023 Q2	$5.25M	Sell	38,953 -9,753	-20%	-$1.43M	0.29%	41
2023 Q1	$7.76M	Sell	48,706 -100	-0.2%	-$15.3K	0.45%	29
2022 Q4	$7.89M	Buy	48,806 +4,683	+11%	+$718K	0.48%	28
2022 Q3	$5.92M	Buy	44,123 +5,698	+15%	+$818K	0.4%	31
2022 Q2	$5.88M	Sell	38,425 -603	-2%	-$92.1K	0.37%	37
2022 Q1	$6.33M	Sell	39,028 -334	-0.8%	-$48.5K	0.35%	34
2021 Q4	$5.33M	Sell	39,362 -6,397	-14%	-$756K	0.28%	41
2021 Q3	$4.94M	Sell	45,759 -5,383	-11%	-$615K	0.28%	40
2021 Q2	$5.76M	Sell	51,142 -2,426	-5%	-$273K	0.32%	37
2021 Q1	$5.8M	Sell	53,568 -2,073	-4%	-$222K	0.35%	34
2020 Q4	$5.96M	Sell	55,641 -11,201	-17%	-$1.08M	0.38%	35
2020 Q3	$5.86M	Sell	66,842 -2,853	-4%	-$269K	0.42%	34
2020 Q2	$6.84M	Sell	69,695 -6,215	-8%	-$547K	0.52%	28
2020 Q1	$5.78M	Sell	75,910 -3,444	-4%	-$293K	0.51%	33
2019 Q4	$7.03M	Sell	79,354 -12,914	-14%	-$1.07M	0.48%	37
2019 Q3	$6.99M	Sell	92,268 -10,853	-11%	-$744K	0.52%	36
2019 Q2	$7.5M	Sell	103,121 -470	-0.5%	-$36.9K	0.56%	35
2019 Q1	$8.35M	Sell	103,591 -113	-0.1%	-$9.24K	0.64%	28
2018 Q4	$9.56M	Sell	103,704 -4,044	-4%	-$356K	0.83%	20
2018 Q3	$10.2M	Sell	107,748 -1,585	-1%	-$150K	0.78%	23
2018 Q2	$10.1M	Buy	109,333 +277	+0.3%	+$27.1K	0.84%	21
2018 Q1	$10.3M	Buy	109,056 +513	+0.5%	+$56.4K	0.86%	22
2017 Q4	$10.5M	Sell	108,543 -6,901	-6%	-$650K	0.86%	21
2017 Q3	$10.3M	Sell	115,444 -22,360	-16%	-$1.7M	0.87%	24
2017 Q2	$9.99M	Sell	137,804 -10,081	-7%	-$678K	0.87%	25
2017 Q1	$9.64M	Sell	147,885 -1,761	-1%	-$111K	0.87%	24
2016 Q4	$9.37M	Buy	149,646 +25,060	+20%	+$1.53M	0.87%	27
2016 Q3	$7.86M	Buy	124,586 +8,610	+7%	+$557K	0.72%	36
2016 Q2	$7.18M	Sell	115,976 -22,805	-16%	-$1.39M	0.77%	33
2016 Q1	$7.93M	Buy	138,781 +6,539	+5%	+$364K	0.85%	30
2015 Q4	$7.83M	Sell	132,242 -11,586	-8%	-$667K	0.9%	30
2015 Q3	$7.83M	Sell	143,828 -4,701	-3%	-$306K	0.91%	28
2015 Q2	$9.98M	Sell	148,529 -8,997	-6%	-$587K	1.04%	19
2015 Q1	$9.22M	Buy	157,526 +3,123	+2%	+$189K	0.9%	22
2014 Q4	$10.1M	Sell	154,403 -6,856	-4%	-$432K	0.94%	19
2014 Q3	$9.31M	Sell	161,259 -28,092	-15%	-$1.56M	0.87%	22
2014 Q2	$10.7M	Sell	189,351 -28,904	-13%	-$1.52M	1.01%	17
2014 Q1	$11.2M	Sell	218,255 -7,918	-4%	-$400K	1.12%	15
2013 Q4	$11.9M	Sell	226,173 -4,021	-2%	-$198K	1.2%	14
2013 Q3	$10.3M	Buy	230,194 +12,531	+6%	+$555K	1.08%	15
2013 Q2	$9M	Buy	+217,663	New	+$9.52M	0.97%	20

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of Hawaii's ABBV Position: Q1 2026 in Review

Bank of Hawaii reduced its AbbVie (ABBV) stake by 9.3% in Q1 2026, selling an estimated $599K and leaving 26,176 shares worth $5.69M. The position accounts for 0.3% of the portfolio, ranked #46.

Bank of Hawaii first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.9M in Q4 2013. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Bank of Hawaii held 26,176 shares of AbbVie worth $5.69M as of Q1 2026.
Bank of Hawaii sold 2,699 AbbVie shares in Q1 2026, an estimated $599K.
AbbVie made up 0.3% of Bank of Hawaii's portfolio in Q1 2026, its #46 holding.
Bank of Hawaii first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Bank of Hawaii's AbbVie position peaked at $11.9M in Q4 2013.
4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Bank of Hawaii's 13F filing for Q1 2026, filed 15 May 2026.